Patient-specific decisions about hormone replacement therapy in postmenopausal women

Col, Nananda F.

doi:10.1001/jama.1997.03540380054031

Cited by 229Menopause: Health Impacts and TreatmentsHormonal and reproductive studiesEstrogen and related hormone effects

Patient-specific decisions about hormone replacement therapy in postmenopausal women

Col, Nananda F.·1997·JAMA: The Journal of the American Medical Association

DOI 10.1001/jama.1997.03540380054031

Open this paper in CoChat — free account

Abstract

Objective To examine the effect of hormone replacement therapy on life expectancy in postmenopausal women with different risk profiles for heart disease, breast cancer, and hip fracture. Design Decision analysis using a Markov model. Published regression models were used to link risk factors to disease incidence and to estimate the lifetime risks of developing coronary heart disease (CHD), breast cancer, hip fracture, and endometrial cancer. The impact of hormone therapy on disease incidence was estimated from published epidemiologic studies. Setting Mathematical model applicable to primary care. Interventions Treatment with hormone replacement therapy or no hormone replacement therapy. Main outcome measure Life expectancy. Results Hormone replacement therapy should increase life expectancy for nearly all postmenopausal women, with some gains exceeding 3 years, depending mainly on an individual's risk factors for CHD and breast cancer. For women with at least 1 risk factor for CHD, hormone therapy should extend life expectancy, even for women having first-degree relatives with breast cancer. Women without any risk factors for CHD or hip fracture, but who have 2 first-degree relatives with breast cancer, however, should not receive hormone therapy. Conclusions The benefit of hormone replacement therapy in reducing the likelihood of developing CHD appears to outweigh the risk of breast cancer for nearly all women in whom this treatment might be considered. Our analysis supports…

Integrity signals

Registry

Crossref · 10.1001/jama.1997.03540380054031

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

STMs used to evaluate primary prevention strategies are concerned with reduction in the risk of developing a disease.
“STMs used to evaluate primary prevention strategies are concerned with reduction in the risk of developing a disease (e.g., [15]).”
From State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012) · cites this paper as [15]

Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595 · see citing works
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334 · see citing works
Hip fractures in the elderly: A world-wide projection
Cooper, C. C., Campion, G., & Melton, L. J. (1992) · Osteoporosis International · doi:10.1007/bf01623184 · Cited by 3,225 · see citing works
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D. M., Ettinger, B. B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,329 · see citing works
Untitled work
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320 · see citing works
Cardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163 · see citing works
Postmenopausal Estrogen Therapy and Cardiovascular Disease
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 2,000 · see citing works
An updated coronary risk profile. A statement for health professionals.
Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834 · see citing works
Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
Stampfer, M. J., & Colditz, G. A. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90006-p · Cited by 1,611 · see citing works
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487 · see citing works
Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
Grodstein, F., Stampfer, M. J., Manson, J. E., Colditz, G. A., Willett, W. C., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350701 · Cited by 1,294 · see citing works
Menopause and the Risk of Coronary Heart Disease in Women
Colditz, G. A., Willett, W. C., Stampfer, M. J., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704303161801 · Cited by 1,153 · see citing works
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
Grady, D., Gebretsadik, T. S., Kerlikowske, K. M., Ernster, V. L., & Petitti, D. B. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(94)00383-o · Cited by 958 · see citing works
The Markov process in medical prognosis
Beck, J. R., & Pauker, S. G. (1983) · Medical Decision Making · doi:10.1177/0272989x8300300403 · Cited by 957 · see citing works
A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease
Stampfer, M. J., Willett, W. C., Colditz, G. A., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510243131703 · Cited by 855 · see citing works
Estrogen Replacement Therapy and Fractures in Older Women
Cauley, J. A., Seeley, D. G., Ensrud, K. E., Ettinger, B., Black, D., & Cummings, S. R. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00002 · Cited by 808 · see citing works
Cardiovascular Health and Disease in Women
WENGER, N. K., Speroff, L., & Packard, B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307223290406 · Cited by 801 · see citing works
Long-Term Estrogen Replacement Therapy Prevents Bone Loss and Fractures
Ettinger, B. B., GENANT, H. K., & CANN, C. E. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-3-319 · Cited by 774 · see citing works
Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
Weiss, N. S., Ure, C. L., Ballard, J. H., Williams, A. R., & Daling, J. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032102 · Cited by 774 · see citing works
The Lifetime Risk of Developing Breast Cancer
Feuer, E. J., Wun, L., Boring, C. C., Flanders, W. D., Timmel, M. J., & Tong, T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.892 · Cited by 640 · see citing works
Decreased Mortality in Users of Estrogen Replacement Therapy
HENDERSON, B. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010095012 · Cited by 634 · see citing works
A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer
STEINBERG, K. K. (1991) · JAMA · doi:10.1001/jama.1991.03460150089030 · Cited by 629 · see citing works
Hip Fracture and the Use of Estrogens in Postmenopausal Women
Kiel, D. P., Felson, D. T., Anderson, J. J., Wilson, P. W. F., & Moskowitz, M. A. (1988) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198807000-00018 · Cited by 625 · see citing works
Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women
Judd, H. L. (1996) · JAMA · doi:10.1001/jama.1996.03530290040035 · Cited by 605 · see citing works
Incidence of and Treatment for Ductal Carcinoma In Situ of the Breast
Ernster, V. L. (1996) · JAMA · doi:10.1001/jama.1996.03530360023033 · Cited by 600 · see citing works
A convenient approximation of life expectancy (the “DEALE”)
Beck, J. R., Pauker, S. G., Gottlieb, J. E., Klein, K., & Kassirer, J. P. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90787-2 · Cited by 481 · see citing works
Menopausal Estrogen Therapy and Hip Fractures
Paganini‐Hill, A., Ross, R. K., Gerkins, V. R., Henderson, B. E., ARTHUR, M., & Mack, T. M. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-1-28 · Cited by 468 · see citing works
Hip fracture mortality. Relation to age, treatment, preoperative illness, time of surgery, and complications.
Kenzora, J. E., Re, M., Lowell, J. D., & Cb, S. (1984) · PubMed · Cited by 460 · see citing works
POST-MENOPAUSAL $OElig;STROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control Study
HUTCHINSON, T. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90640-8 · Cited by 452 · see citing works
Hip Fracture Mortality
Kenzora, J. E., MCCARTHY, R. E., DRENNAN, J., & SLEDGE, C. B. (1984) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198406000-00008 · Cited by 449 · see citing works
A convenient approximation of life expectancy (the “DEALE”)
Beck, J. R., Kassirer, J. P., & Pauker, S. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90786-0 · Cited by 413 · see citing works
Surveillance, epidemiology, and end results: incidence and mortality data, 1973-77.
Young, J. L., Percy, C., & Asire, A. J. (1981) · PubMed · Cited by 413 · see citing works
Perceptions of Breast Cancer Risk and Screening Effectiveness in Women Younger Than 50 Years of Age
Black, W. C., Nease, R. F., & Tosteson, A. N. A. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.720 · Cited by 411 · see citing works
Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women
Sullivan, J. M. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.12.2557 · Cited by 399 · see citing works
Race and sex differences in hip fracture incidence.
Farmer, M. E., White, L. R., Brody, J. A., & Bailey, K. R. (1984) · American Journal of Public Health · doi:10.2105/ajph.74.12.1374 · Cited by 395 · see citing works
Survival experience of aged hip fracture patients.
Magaziner, J. S., Simonsick, E. M., Kashner, T. M., Hebel, J. R., & Kenzora, J. E. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.3.274 · Cited by 383 · see citing works
Estrogen Replacement Therapy and Risk of Fatal Colon Cancer in a Prospective Cohort of Postmenopausal Women
Calle, E. E., Miracle-McMahill, H. L., Thun, M. J., & Heath, C. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.7.517 · Cited by 360 · see citing works
Postmenopausal oestrogen treatment and stroke: a prospective study.
Paganini‐Hill, A., Ross, R. K., & Henderson, B. E. (1988) · BMJ · doi:10.1136/bmj.297.6647.519 · Cited by 344 · see citing works
Combined Estrogen and Progestin Hormone Replacement Therapy in Relation to Risk of Breast Cancer in Middle-aged Women
Stanford, J. L. (1995) · JAMA · doi:10.1001/jama.1995.03530020055032 · Cited by 337 · see citing works
AN EPIDEMIOLOGIC STUDY OF HIP FRACTURE IN POSTMENOPAUSAL WOMEN
Kreiger, N., Kelsey, J. L., Holford, T. R., & O’Connor, T. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113388 · Cited by 336 · see citing works
The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement
Falkeborn, M., Persson, I. R., Adami, H., Bergström, R., Eaker, E. D., Lithell, H., Mohsen, R., & Naessén, T. (1992) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb14414.x · Cited by 334 · see citing works
An Epidemiologic Study of Cervical and Trochanteric Fractures of the Femur in an Urban Population Analysis of 1,664 Cases with Special Reference to Etiologic Factors
Alffram, P.-A. (1964) · Acta Orthopaedica Scandinavica · doi:10.3109/ort.1964.35.suppl-65.01 · Cited by 317 · see citing works
Rate of mortality for elderly patients after fracture of the hip in the 1980's.
Bl, W., Fisher, W. R., & Laurin, C. A. (1987) · PubMed · Cited by 310 · see citing works
Bone Mineral Density and Risk of Breast Cancer in Older Women
Cauley, J. A. (1996) · JAMA · doi:10.1001/jama.1996.03540170048031 · Cited by 290 · see citing works
The Comparative Effect on Bone Density, Endometrium, and Lipids of Continuous Hormones as Replacement Therapy (CHART Study)
Speroff, L. (1996) · JAMA · doi:10.1001/jama.1996.03540170041030 · Cited by 264 · see citing works
Decision Analysis: A Progress Report
Kassirer, J. P., MOSKOWITZ, A. J., LAU, J., & PAUKER, S. G. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-275 · Cited by 262 · see citing works
Race and sex differences in mortality following fracture of the hip.
Jacobsen, S. J., Goldberg, J., Miles, T. P., Brody, J. A., Stiers, W. M., & Rimm, A. A. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.8.1147 · Cited by 254 · see citing works
Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort
Finucane, F. F. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.1.73 · Cited by 246 · see citing works
Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior.
Lerman, C., Kash, K. M., & Stefanek, M. E. (1994) · PubMed · Cited by 244 · see citing works
PROGNOSIS AFTER BREAST CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY
Bergkvist, L., Adami, H., Persson, I. R., BERGSTROM, R., & Krusemo, U. B. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115328 · Cited by 239 · see citing works
Functional recovery after fracture of the hip.
Koval, K. J., & Zuckerman, J. D. (1994) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199405000-00018 · Cited by 237 · see citing works
Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited
Barrett-Connor, E. L. (1989) · JAMA · doi:10.1001/jama.261.14.2095 · Cited by 237 · see citing works
Estrogen replacement therapy and protection from acute myocardial infarction
Henderson, B. E., Paganini‐Hill, A., & Ross, R. K. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(88)80074-7 · Cited by 234 · see citing works
Postmenopausal Hormone Use and Risk of Large-Bowel Cancer
Newcomb, P. A., & Storer, B. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.14.1067 · Cited by 231 · see citing works
Expected Gains in Life Expectancy From Various Coronary Heart Disease Risk Factor Modifications
Tsevat, J., Weinstein, M., Williams, L., Tosteson, A., & Goldman, L. (1991) · Circulation · doi:10.1161/01.cir.83.4.1194 · Cited by 226 · see citing works
Cost Effectiveness of Screening Perimenopausal White Women for Osteoporosis: Bone Densitometry and Hormone Replacement Therapy
Tosteson, A. N. A., Rosenthal, D. I., Melton, L. J., & Weinstein, M. C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-8-594 · Cited by 221 · see citing works
Factors Affecting Hip Fracture Mortality
Sexson, S. B., & Lehner, J. T. (1987) · Journal of Orthopaedic Trauma · doi:10.1097/00005131-198701040-00005 · Cited by 218 · see citing works
Hormone Replacement Therapy and the Risk for First Hip Fracture
Naessén, T., Persson, I., Adami, H., Bergström, R., & Bergkvist, L. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-2-95 · Cited by 211 · see citing works
Mortality and Life Expectancy After hip Fractures
Dahl, E. (1980) · Acta Orthopaedica Scandinavica · doi:10.3109/17453678008990781 · Cited by 211 · see citing works
Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis
Ryan, P. J., Harrison, R. M., Blake, G. M., & Fogelman, I. (1992) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb13732.x · Cited by 203 · see citing works
Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women.
Ar, W., Ns, W., Ure, C. L., Ballard, J. H., & Daling, J. R. (1982) · PubMed · Cited by 201 · see citing works
Hip Fracture Incidence and Mortality in New England
Fisher, E. S., Baron, J. A., Malenka, D. J., BARRETT, J. A., Kniffin, W. D., Whaley, F. S., & Bubolz, T. A. (1991) · Epidemiology · doi:10.1097/00001648-199103000-00005 · Cited by 190 · see citing works
Adding Insult to Injury
Kassirer, J. P. (1983) · New England Journal of Medicine · doi:10.1056/nejm198304143081511 · Cited by 188 · see citing works
The Toss-up
Kassirer, J. P., & Pauker, S. G. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052409 · Cited by 186 · see citing works
Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?
Potshuma, W. F. M., Westendorp, R. G. J., & Vandenbroucke, J. P. (1994) · BMJ · doi:10.1136/bmj.308.6939.1268 · Cited by 165 · see citing works
Cancer Patient Survival: Surveillance, Epidemiology, and End Results Program, 1973–79
Ries, L. G., Pollack, E. S., & Young, J. L. (1983) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/70.4.693 · Cited by 156 · see citing works
Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered
Hillner, B. E., Hollenberg, J. P., & Pauker, S. G. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90674-1 · Cited by 128 · see citing works
Early failures among 14,009 cemented and 1,326 uncemented prostheses for primary coxarthrosis: The Norwegian Arthroplasty Register, 1987-1992
Havelin, L. I., Espehaug, B., Se, V., & Engesaeter, L. B. (1994) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679408993706 · Cited by 123 · see citing works
The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.
Thompson, S. G., Meade, T. W., & Greenberg, G. M. (1989) · Journal of Epidemiology & Community Health · doi:10.1136/jech.43.2.173 · Cited by 117 · see citing works
?
Udoff, L. C. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00115-8 · Cited by 116 · see citing works
Attitudes of women toward hormone therapy and prevention of heart disease
Pilote, L., & Hlatky, M. A. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90426-3 · Cited by 109 · see citing works
Clinical and Biologic Prognostic Factors in Breast Cancer Diagnosed During Postmenopausal Hormone Replacement Therapy
Bonnier, P. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(94)00324-7 · Cited by 109 · see citing works
Comparison of physicians' decisions regarding estrogen replacement therapy for menopausal women and decisions derived from a decision analytic model
Elstein, A. S., Holzman, G. B., Ravitch, M. M., Metheny, W. A., Holmes, M. M., Hoppe, R. B., Rothert, M. L., & Rovner, D. R. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90016-1 · Cited by 102 · see citing works
The risk of hip fracture in postmenopausal females with or without estrogen drug exposure.
Johnson, R. E., & Specht, E. E. (1981) · American Journal of Public Health · doi:10.2105/ajph.71.2.138 · Cited by 101 · see citing works
Mortality after cervical hip fracture: 3002 patients followed for 6 years
Holmberg, S., Conradi, P., Kalén, R., & Thorngren, K. (1986) · Acta Orthopaedica Scandinavica · doi:10.3109/17453678608993205 · Cited by 97 · see citing works
Postmenopausal estrogen replacement: A long-term cohort study
Lafferty, F. W., & Fiske, M. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90050-7 · Cited by 92 · see citing works
Clinical decision analysis by personal computer
Pauker, S. G. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.13.1831 · Cited by 90 · see citing works
A Review of the Association of Estrogens and Progestins With Cardiovascular Disease in Postmenopausal Women
Psaty, B. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410120009002 · Cited by 86 · see citing works
Health status before and mortality after hip fracture.
Katelaris, A., & Cumming, R. G. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.4.557 · Cited by 80 · see citing works
Estrogen replacement therapy. A survey of older women's attitudes
Salamone, L. M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.12.1293 · Cited by 78 · see citing works
Decision Maker 3.0
Lau, J., Kassirer, J. P., & Pauker, S. G. (1983) · Medical Decision Making · doi:10.1177/0272989x8300300110 · Cited by 74 · see citing works
Relative risks and benefits of long‐term estrogen replacement therapy: A decision analysis
Gorsky, R. D., Koplan, J. P., Peterson, H. B., & Thacker, S. B. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90483-9 · Cited by 74 · see citing works
The relationship between breast cancer survival and prior postmenopausal estrogen use.
Strickland, D., Gambrell, R. D., Butzin, C. A., & Strickland, K. (1992) · PubMed · Cited by 72 · see citing works
Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy
Meade, T. W. (1996) · BMJ · doi:10.1136/bmj.312.7029.473 · Cited by 71 · see citing works
ESTROGEN USE AND STROKE RISK IN POSTMENOPAUSAL WOMEN1
PFEFFER, R. I., & van den Noort, S. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112246 · Cited by 71 · see citing works
Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women
Dören, M., Reuther, G., Minne, H. W., & Schneider, H. P. G. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90631-2 · Cited by 70 · see citing works
Evaluation of ovarian findings in asymptomatic postmenopausal women with color doppler ultrasound
Vuento, M., PIRHONEN, J. P., Mäkinen, J., Laippala, P. J., Grönroos, M. A., & Salmi, T. (1995) · Cancer · doi:10.1002/1097-0142(19951001)76:7 · Cited by 65 · see citing works
Ten-Year Survival after Fractures of the Proximal End of the Femur
Elmerson, S., Zetterberg, C., & Andersson, G. B. J. (2009) · Gerontology · doi:10.1159/000212951 · Cited by 63 · see citing works
Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study.
Risch, H. A., & Howe, G. R. (1995) · PubMed · Cited by 61 · see citing works
The probability of death following a fracture of the hip.
Gordon, P. C. (1971) · PubMed Central · Cited by 57 · see citing works
Estrogen: Key Player in Heart Disease Among Women
Gura, T. (1995) · Science · doi:10.1126/science.7543696 · Cited by 52 · see citing works
Colorectal cancer and oestrogen replacement therapy: A meta‐analysis of epidemiological studies
MacLennan, S. C., MacLennan, A. H., & Ryan, P. (1995) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1995.tb140014.x · Cited by 49 · see citing works
Estrogen and interrupted progestin: A new concept for menopausal hormone replacement therapy
Casper, R. F., & Chapdelaine, A. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90367-r · Cited by 46 · see citing works
12 Cost-effectiveness of hormone replacement therapy after the menopause
Tosteson, A. N. A., & Weinstein, M. C. (1991) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80298-6 · Cited by 46 · see citing works
Life expectancy biases in clinical decision modeling
Kuntz, K. M., & Weinstein, M. C. (1995) · Medical Decision Making · doi:10.1177/0272989x9501500209 · Cited by 38 · see citing works
How do physicians weigh iatrogenic complications?
Cohen, B. J., & Pauker, S. G. (1994) · Journal of General Internal Medicine · doi:10.1007/bf02599137 · Cited by 37 · see citing works
Hormone replacement and breast cancer. A remaining controversy?
Adami, H. (1995) · JAMA · doi:10.1001/jama.274.2.178 · Cited by 37 · see citing works
Fractures of the hip—Mortality survey
Reno, J. H., & Burlington, H. (1958) · The American Journal of Surgery · doi:10.1016/0002-9610(58)90440-9 · Cited by 23 · see citing works
Estimated gains in life expectancy with use of postmenopausal estrogen therapy: a decision analysis.
Zubialde, J. P., Lawler, F. H., & Clemenson, N. (1993) · PubMed · Cited by 18 · see citing works
Antilymphoblastic Globulin in Renal Transplant Patients: No Allergic Reactions: A Correction
Chou, S. N. (1995) · JAMA · doi:10.1001/jama.1995.03530210030024 · Cited by 15 · see citing works
Effectiveness and Efficacy—Which Is Which?
Franklin, C. M. (1994) · Critical Care Medicine · doi:10.1097/00003246-199408000-00019 · Cited by 2 · see citing works

Flagged first, then by citations

Sorted by citations

Dietary Isoflavones: Biological Effects and Relevance to Human Health
Setchell, K. D. R., & Cassidy, A. (1999) · Journal of Nutrition · doi:10.1093/jn/129.3.758s · Cited by 1,158 · see citing works
Cardiovascular Disease in Women
Mosca, L. J., Manson, J. E., Sutherland, S. E., Langer, R. D., Manolio, T. A., & Barrett-Connor, E. L. (1997) · Circulation · doi:10.1161/01.cir.96.7.2468 · Cited by 731 · see citing works
Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women
Walsh, B. W. (1998) · JAMA · doi:10.1001/jama.279.18.1445 · Cited by 691 · see citing works
The Treatment of Unrelated Disorders in Patients with Chronic Medical Diseases
Redelmeier, D. A., Tan, S. H., & Booth, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382106 · Cited by 635 · see citing works
HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
Barrett-Connor, E. L., & Grady, D. G. (1998) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.19.1.55 · Cited by 586 · see citing works
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M. (2012) · Value in Health · doi:10.1016/j.jval.2012.06.014 · Cited by 495 · see citing works
The menopause
Greendale, G. A., Lee, N. P., & Arriola, E. R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05352-5 · Cited by 467 · see citing works
KEEPS: The Kronos Early Estrogen Prevention Study
Harman, S. M., Brinton, E., Cedars, M. I., Løbo, R. A., Manson, J., Merriam, G. R., Miller, V., Naftolin, F. N., & Santoro, N. F. (2005) · Climacteric · doi:10.1080/13697130500042417 · Cited by 392 · see citing works
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
Pfeilschifter, J., & Diel, I. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1570 · Cited by 363 · see citing works
Postmenopausal syndrome
Dalal, P., & Agarwal, M. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.161483 · Cited by 367 · see citing works
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–3
Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M. (2012) · Medical Decision Making · doi:10.1177/0272989x12455463 · Cited by 348 · see citing works
Use of Hormone Replacement Therapy by Postmenopausal Women in the United States
Keating, N. L., Cleary, P. D., Rossi, A. S., Zaslavsky, A. M., & Ayanian, J. Z. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00002 · Cited by 329 · see citing works
Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results
Haas, J. S., Kaplan, C. P., Gerstenberger, E. P., & Kerlikowske, K. M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00009 · Cited by 314 · see citing works
Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy
Hlatky, M. A., Boothroyd, D. B., Vittinghoff, E., Sharp, P. C., & Whooley, M. A. (2002) · JAMA · doi:10.1001/jama.287.5.591 · Cited by 302 · see citing works
Randomized Trial of a Portable, Self-administered Decision Aid for Postmenopausal Women Considering Long-term Preventive Hormone Therapy
O'Connor, A. M. C., Tugwell, P., Wells, G. A., Elmslie, T., JOLLY, E. E., Hollingworth, G. R., McPherson, R., Drake, E. R., Hopman, W. M., & Mackenzie, T. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800307 · Cited by 248 · see citing works
Primary Care for Survivors of Breast Cancer
Burstein, H. J., & Winer, E. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431506 · Cited by 241 · see citing works
Effect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration
Espeland, M. A., Marcovina, S. M., Miller, V. T., Wood, P. D., Wasilauskas, C. H., Sherwin, R. W., Schrott, H. G., & Bush, T. L. (1998) · Circulation · doi:10.1161/01.cir.97.10.979 · Cited by 186 · see citing works
The physiology, medical management and oral implications of menopause
Friedlander, A. H. (2002) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2002.0025 · Cited by 165 · see citing works
Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With BRCA1/2 Mutations: A Decision Analysis
Armstrong, K., Schwartz, J. S., Randall, T. C., Rubin, S. C., & Weber, B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.090 · Cited by 161 · see citing works
Identifying patient preferences for communicating risk estimates: A descriptive pilot study
Fortin, J. M., Hirota, L. K., Bond, B., O'Connor, A. M. C., & Col, N. F. (2001) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-1-2 · Cited by 153 · see citing works
Self-citation
Estrogen interacts with the IGF‐1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6‐hydroxdopamine lesions
Quesada, A., & Micevych, P. E. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10833 · Cited by 147 · see citing works
Hormone Replacement Therapy and Heart Disease Prevention
Petitti, D. B. (1998) · JAMA · doi:10.1001/jama.280.7.650 · Cited by 142 · see citing works
Using Basic Science to Design a Clinical Trial: Baseline Characteristics of Women Enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)
Miller, V. M., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hodis, H. N., Løbo, R. A., Manson, J. E., Merriam, G. R., Naftolin, F. N., et al. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9104-y · Cited by 136 · see citing works
LY353381.HCl: A Novel Raloxifene Analog with Improved SERM Potency and Efficacy In Vivo
Sato, M., Turner, C. H., Wang, T., Adrian, M. D., Rowley, E. R., & Bryant, H. U. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37755-9 · Cited by 134 · see citing works
Postmenopausal hormone therapy: risks and benefits
Rozenberg, S., Vandromme, J., & Antoine, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.17 · Cited by 132 · see citing works
Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study
Schairer, C., Gail, M. H., Byrne, C., Rosenberg, P. S., Sturgeon, S. R., Brinton, L. A., & Hoover, R. N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.264 · Cited by 124 · see citing works
Prescribing for Seniors
Rochon, P. A. (1999) · JAMA · doi:10.1001/jama.282.2.113 · Cited by 123 · see citing works
Where Are We Going?
Santoro, N. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5765-1 · Cited by 122 · see citing works
Decision analysis and the implementation of research findings
Lilford, R. J., Pauker, S. G., Braunholtz, D., & Chard, J. (1998) · BMJ · doi:10.1136/bmj.317.7155.405 · Cited by 116 · see citing works
Timing and Duration of Menopausal Hormone Treatment May Affect Cardiovascular Outcomes
Harman, S. M., Vittinghoff, E., Brinton, E. A., Budoff, M. J., Cedars, M. I., Løbo, R. A., Merriam, G. R., Miller, V. M., Naftolin, F. N., Pal, L., et al. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.09.021 · Cited by 111 · see citing works
Development and pilot testing of a decision aid for postmenopausal women with osteoporosis
Cranney, A., O'Connor, A. M. C., Jacobsen, M. J., Tugwell, P., Adachi, J. D., Ooi, D. S., Waldegger, L., Goldstein, R., & Wells, G. A. (2002) · Patient Education and Counseling · doi:10.1016/s0738-3991(01)00218-x · Cited by 105 · see citing works
MENOPAUSE AND HORMONE REPLACEMENT THERAPY
Johnson, S. R. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70608-8 · Cited by 104 · see citing works
Is the Estrogen Controversy Over? Deconstructing the Women's Health Initiative Study: A Critical Evaluation of the Evidence
Harman, S. M., Naftolin, F. N., Brinton, E. A., & Judelson, D. R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1347.004 · Cited by 95 · see citing works
The Role of Hormone Replacement Therapy in the Prevention of Postmenopausal Heart Disease
Mosca, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2263 · Cited by 87 · see citing works
Healthcare Use among U.S. Women Aged 45 and Older: Total Costs and Costs for Selected Postmenopausal Health Risks
Hoerger, T. J., DOWNS, K. E., Lakshmanan, M. C., Lindrooth, R. C., Plouffe, L., Wendling, B. W., West, S. L., & Ohsfeldt, R. L. (1999) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/jwh.1.1999.8.1077 · Cited by 78 · see citing works
The pharmacokinetics and efficacy of different estrogens are not equivalent
Ansbacher, R. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.109656 · Cited by 72 · see citing works
Current perspectives on benefits and risks of hormone replacement therapy
Burkman, R. T., Collins, J. A., & Greene, R. A. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117414 · Cited by 72 · see citing works
A randomized trial of a computerized versus an audio-booklet decision aid for women considering post-menopausal hormone replacement therapy
Rostom, A., O'Connor, A. M. C., Tugwell, P., & Wells, G. A. (2002) · Patient Education and Counseling · doi:10.1016/s0738-3991(01)00167-7 · Cited by 71 · see citing works
Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK
Daya, S., Ledger, W. J., Auray, J., Duru, G., Silverberg, K. M., Wikland, M., Bouzayen, R., Howles, C. M., & Béresniak, A. (2001) · Human Reproduction · doi:10.1093/humrep/16.12.2563 · Cited by 66 · see citing works
Prescribing Hormone Replacement Therapy for Menopausal Symptoms
McNagny, S. E. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-8-199910190-00010 · Cited by 65 · see citing works
Benefits and harms associated with hormone replacement therapy: clinical decision analysis
Minelli, C., Abrams, K. R., Sutton, A. J., & Cooper, N. J. (2004) · BMJ · doi:10.1136/bmj.328.7436.371 · Cited by 63 · see citing works
Role of Estrogens in the Management of Postmenopausal Bone Loss
Gallagher, J. C. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70191-5 · Cited by 62 · see citing works
Is the WHI Relevant to HRT Started in the Perimenopause?
Harman, S. M., Brinton, E. A., Clarkson, T. B., Heward, C. B., Hecht, H. S., Karas, R. H., Judelson, D. R., & Naftolin, F. N. (2004) · Endocrine · doi:10.1385/endo:24:3:195 · Cited by 57 · see citing works
Phyto-oestrogens through the life cycle
Cassidy, A., & Faughnan, M. S. (2000) · Proceedings of The Nutrition Society · doi:10.1017/s0029665100000719 · Cited by 59 · see citing works
Individualizing Therapy to Prevent Long-term Consequences of Estrogen Deficiency in Postmenopausal Women
Col, N. F., Pauker, S. G., Goldberg, R. J., Eckman, M. H., Orr, R. K., Ross, E. M., & Wong, J. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.13.1458 · Cited by 57 · see citing works
Self-citation
Healthy Women with a Family History of Breast Cancer: Impact of a Tailored Genetic Counseling Intervention on Risk Perception, Knowledge, and Menopausal Therapy Decision Making
Matloff, E. T., Moyer, A. E., Shannon, K. M., Niendorf, K. B., & Col, N. F. (2006) · Journal of Women s Health · doi:10.1089/jwh.2006.15.843 · Cited by 56 · see citing works
Self-citation
The impact of clinical trials on the use of hormone replacement therapy
Kim, N. V., Gross, C. P., Curtis, J. P., Stettin, G., Wogen, S. E., Choe, N., & Krumholz, H. M. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0221.x · Cited by 54 · see citing works
Economic Evaluation of Weight Loss Interventions in Overweight and Obese Women
Roux, L., Kuntz, K. M., Donaldson, C., & Goldie, S. J. (2006) · Obesity · doi:10.1038/oby.2006.125 · Cited by 56 · see citing works
The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease
Sbarouni, E., Kyriakides, Z. S., & Kremastinos, D. T. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00413-6 · Cited by 52 · see citing works
Bioidentical hormones, menopausal women, and the lure of the “natural” in U.S. anti-aging medicine
Fishman, J. R., Flatt, M. A., & Settersten, R. A. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.02.027 · Cited by 51 · see citing works
Low rates of hormone replacement in visits to United States primary care physicians
Stafford, R. S., Saglam, D., Causino, N., & Blumenthal, D. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70202-3 · Cited by 51 · see citing works
Soybean Isoflavones: Effects of Processing and Health Benefits
Faraj, A. K., & Vasanthan, T. (2004) · Food Reviews International · doi:10.1081/fri-120028830 · Cited by 48 · see citing works
A Mouse Model to Study the Effects of Hormone Replacement Therapy on Normal Mammary Gland during Menopause: Enhanced Proliferative Response to Estrogen in Late Postmenopausal Mice
Raafat, A. M., Hofseth, L. J., Li, S., Bennett, J. M., & Haslam, S. Z. (1999) · Endocrinology · doi:10.1210/en.140.6.2570 · Cited by 48 · see citing works
Avaliação tecnológica em saúde: densitometria óssea e terapêuticas alternativas na osteoporose pós-menopausa
Silva, L. K. (2003) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2003000400022 · Cited by 47 · see citing works
Menopausal hormones and breast cancer in a biracial population
Moorman, P. G., Kuwabara, H., Millikan, R. C., & Newman, B. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.6.966 · Cited by 47 · see citing works
Gynecological health of females with congenital heart disease
Canobbio, M. M., Perloff, J. K., & Rapkin, A. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.021 · Cited by 47 · see citing works
Phyto-oestrogens: A potential role in the prevention of CHD?
Cassidy, A., & Griffin, B. A. (1999) · Proceedings of The Nutrition Society · doi:10.1079/pns19990025 · Cited by 46 · see citing works
The effects of a soy rich diet on serum lipids: the Menfis randomized trial
Chiechi, L. M., Secreto, G., Vimercati, A., Greco, P., Venturelli, E., Pansini, F. S., Fanelli, M., Loizzi, P., & Selvaggi, L. E. (2002) · Maturitas · doi:10.1016/s0378-5122(01)00259-6 · Cited by 46 · see citing works
Progress in osteoporosis and fracture prevention: focus on postmenopausal women
Saag, K. G., & Geusens, P. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2815 · Cited by 45 · see citing works
LY353381·HCl: An Improved Benzothiophene Analog with Bone Efficacy Complementary to Parathyroid Hormone-(1–34)
Sato, M., Zeng, G. Q., Rowley, E. R., & Turner, C. H. (1998) · Endocrinology · doi:10.1210/endo.139.11.6307 · Cited by 45 · see citing works
The proliferation of clinical practice guidelines: professional development or medicine-by-numbers?
Genuis, S. (2005) · The Journal of the American Board of Family Practice · doi:10.3122/jabfm.18.5.419 · Cited by 44 · see citing works
Medical Decision Making
Elstein, A. S., Schwartz, A., & NENDAZ, M. R. (2002) · Springer international handbooks of education · doi:10.1007/978-94-010-0462-6_9 · Cited by 44 · see citing works
Elements of Informed Consent for Hormone Replacement Therapy in Patients With Diagnosed Breast Cancer
Chlebowski, R. T., & McTiernan, A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.130 · Cited by 42 · see citing works
Selective oestrogen receptor modulators - current and future brain and behaviour applications
Halbreich, U. M., & Kahn, L. S. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.7.1385 · Cited by 40 · see citing works
Estrogen Replacement Therapy and Breast Cancer: Analysis of Age of Onset and Tumor Characteristics
Bilimoria, M. M., Winchester, D. J., Sener, S. F., Motykie, G. D., Sehgal, U. L., & Winchester, D. P. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0200-7 · Cited by 40 · see citing works
Hormone Replacement Therapy: Real Concerns and False Alarms
Bluming, A. Z., & Tavris, C. (2009) · The Cancer Journal · doi:10.1097/ppo.0b013e31819e332a · Cited by 38 · see citing works
Life With and Without Heart Disease Among Women and Men Over 50
Crimmins, E. M., Hayward, M. D., Ueda, H., Saito, Y., & Kim, J. K. (2008) · Journal of Women & Aging · doi:10.1300/j074v20n01_02 · Cited by 37 · see citing works
Can Computerized Decision Support Help Patients Make Complex Treatment Decisions? A Randomized Controlled Trial of an Individualized Menopause Decision Aid
Col, N. F., Ngo, L. H., Fortin, J. M., Goldberg, R. J., & O'Connor, A. M. C. (2007) · Medical Decision Making · doi:10.1177/0272989x07306781 · Cited by 37 · see citing works
Self-citation
Estradiol and Dydrogesterone
Foster, R. H., & Balfour, J. A. B. (1997) · Drugs & Aging · doi:10.2165/00002512-199711040-00006 · Cited by 36 · see citing works
Short-term Menopausal Hormone Therapy for Symptom Relief
Col, N. F., Weber, G. M., Stiggelbout, A. M., Chuo, J., D’Agostino, R. B., & Corso, P. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1634 · Cited by 36 · see citing works
Self-citation
Women's midlife health Reframing menopause
Rousseau, M. E. (1998) · Journal of Nurse-Midwifery · doi:10.1016/s0091-2182(98)00005-6 · Cited by 35 · see citing works
Antioxidant effect of estrogen on bovine aortic endothelial cells
Song, J., Kim, M., Jo, H.-H., Hwang, S.-J., Chae, B., Chung, J., Kwon, D.-J., Lew, Y.-O., Lim, Y.-T., Kim, J.-H., et al. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.07.006 · Cited by 34 · see citing works
Shared medical decision-making: A new paradigm for behavioral medicine—1997 presidential address
Kaplan, R. M. (1999) · Annals of Behavioral Medicine · doi:10.1007/bf02895027 · Cited by 33 · see citing works
Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding
Archer, D. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)01036-x · Cited by 32 · see citing works
Raloxifene has favorable effects on the lipid profile in women explaining its beneficial effect on cardiovascular risk: A meta-analysis of randomized controlled trials
Yang, F., Li, N., Găman, M., & Wang, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105512 · Cited by 31 · see citing works
Cardiac Norepinephrine Release: Modulation by Ovariectomy and Estrogen
Eskin, B. A., Snyder, D. L., Roberts, J., & Aloyo, V. J. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800210 · Cited by 31 · see citing works
Menopause: Irish Women’s Voices
Carolan, M. C. (2000) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2000.tb02062.x · Cited by 30 · see citing works
Prevention and Treatment of Osteoporosis: Does the Future Belong to Hormone Replacement Therapy?
Gibaldi, M. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04292.x · Cited by 30 · see citing works
An integrated approach: bisphosphonate management for the treatment of osteoporosis.
Owens, G. M., Jackson, R. D., & Lewiecki, E. M. (2007) · PubMed · Cited by 28 · see citing works
Physician Specialty Is Significantly Associated With Hormone Replacement Therapy Use
Levy, B. T., Ritchie, J. M., Smith, E., Gray, T., & Zhang, W. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02381-5 · Cited by 28 · see citing works
Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum
Harman, S. M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.042 · Cited by 27 · see citing works
Hormone Replacement Therapy After Breast Cancer
Bluming, A. Z. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000595 · Cited by 28 · see citing works
Migraine, Menopause and Hormonal Replacement Therapy
Silberstein, S. D., & Lignieres, B. D. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00044.x · Cited by 27 · see citing works
Low use of long‐term hormone replacement therapy in Denmark
Olesen, C., Steffensen, F. H., Sørensen, H. T., Nielsen, G. L., Olsen, J., & Bergman, U. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00879.x · Cited by 27 · see citing works
Has the Impact of Hormone Replacement Therapy on Health-Related Quality of Life Been Undervalued?
Tosteson, A. N. A., Gabriel, S. E., Kneeland, T. S., Moncur, M. M., Manganiello, P. D., Schiff, I., Ettinger, B. B., & Melton, L. J. (2000) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460900318614 · Cited by 26 · see citing works
Menopausal hormone therapy decisions: insights from a multi-attribute model
Schapira, M. M. (2003) · Patient Education and Counseling · doi:10.1016/s0738-3991(02)00266-5 · Cited by 25 · see citing works
Acute hazards to young children from residential pesticide exposures
Spann, M. F., Blondell, J. M., & Hunting, K. L. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.6.971 · Cited by 24 · see citing works
Hispanic Women's Experience With “el Cambio de Vida”
Longworth, J. C. D. (2003) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2003.tb00397.x · Cited by 24 · see citing works
Women's perceptions of hormone replacement therapy: risks and benefits (1980–2002). A literature review
Buick, D. L., Crook, D., & Horne, R. (2005) · Climacteric · doi:10.1080/13697130500062654 · Cited by 24 · see citing works
Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women
Dias, A. S. M., Melo, R., Gebara, O., D’Amico, É. A., Nussbacher, A., Halbe, H. W., & Pinotti, J. (2005) · Climacteric · doi:10.1080/13697130500042581 · Cited by 24 · see citing works
Hormone replacement therapy: a time for pause.
Yusuf, S., & Anand, S. S. (2002) · Europe PMC (PubMed Central) · Cited by 24 · see citing works
Causal interpretation of correlational studies – Analysis of medical news on the website of the official journal for German physicians
Buhse, S., Rahn, A. C., Bock, M., & Mühlhauser, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196833 · Cited by 24 · see citing works
Does Estrogen Adequately Protect Postmenopausal Women Against Osteoporosis: An Iconoclastic Perspective
ORWOLL, E. S., & Nelson, H. D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.1872 · Cited by 23 · see citing works
Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it
Ekström, H. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.01.010 · Cited by 23 · see citing works
Relative Versus Attributable Risk of Breast Cancer from Estrogen Replacement Therapy
Santen, R. J., & Petroni, G. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.1875 · Cited by 22 · see citing works
Raloxifene Versus Continuous Combined Estrogen/Progestin Therapy: Densitometric and Biochemical Effects in Healthy Postmenopausal Taiwanese Women
Tsai, K., Yen, M., Pan, H., Wu, M., Cheng, W., Hsu, S. H.-J., Yen, B. L., & Huang, K. E. (2001) · Osteoporosis International · doi:10.1007/s001980170011 · Cited by 22 · see citing works
Measuring improved patient choice
Holmes-Rovner, M. M., & Rovner, D. R. (2000) · Journal of Evaluation in Clinical Practice · doi:10.1046/j.1365-2753.2000.00258.x · Cited by 21 · see citing works
Primary Prevention of Postmenopausal Osteoporosis
Levinson, W. S. (1998) · JAMA · doi:10.1001/jama.280.21.1821 · Cited by 21 · see citing works
Beliefs about Breast Cancer Risk and Use of Postmenopausal Hormone Replacement Therapy
Armstrong, K., Popik, S., Guerra, C. E., & Ubel, P. A. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000307 · Cited by 21 · see citing works
Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause
Kaplan, B., Aschkenazi-Steinberg, S. O., Yogev, Y., Nahum, R., Sulkes, J., & Phisher, M. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200209000-00008 · Cited by 21 · see citing works

Decision Analysis Applied to Postmenopausal Hormone Replacement Therapy
Tosteson, A. N. A. (2000) · Elsevier eBooks · doi:10.1016/b978-012453790-3/50047-0
Decision analysis of hormone replacement therapy after the Women's Health Initiative
Kim, C., & Kwok, Y. S. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00778-6 · Cited by 18 · see citing works
Postmenopausal hormone therapy: less favourable risk–benefit ratios in healthy Dutch women
Moerman, C. J., van Hout, B. A., Bonneux, L. G. A., & Witteman, J. C. M. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00714.x · Cited by 11 · see citing works
Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations
Panico, S., Galasso, R., Celentano, E., Ciardullo, A. V., Frova, L., Capocaccia, R., Trevisan, M., & Berrino, F. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.9.1397 · Cited by 13 · see citing works
Hormonal Replacement Therapy for Breast Cancer Survivors: A Decision Analysis
Sacks, H. S. (1999) · doi:10.21236/ada393128

Authors: Col, N. F.
Affiliations: Tufts University (US)
Corresponding author: Col, Nananda F.
ORCID: Col, Nananda F.
Venue: JAMA: The Journal of the American Medical Association
Publisher: American Medical Association (AMA)
Published: 1997-04-09
Volume: 277
Issue: 14
Pages: 1140
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1997.03540380054031
OpenAlex: W1983608420
Cited by: 229
References: 101
Citations by year: 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 4
FWCI: 27.40
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: Agency for Healthcare Research and Quality (1 PO1 HS 06503)
U.S. National Library of Medicine (LM07092, T15LM007092)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords: hormone replacement therapy, postmenopausal women, life expectancy, coronary artery disease, breast cancer, hip fracture, endometrial cancer, cardiovascular risk factors, family history of breast cancer, individualized treatment decision-making
MeSH terms: Aged, Breast Neoplasms, Coronary Disease, Decision Support Techniques, Female, Hip Fractures, Humans, Life Expectancy, Middle Aged, Models, Theoretical, Risk, Risk Factors, Sensitivity and Specificity, Estrogen Replacement Therapy, Endometrial Neoplasms, Postmenopause, Black People, White People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Patient-specific decisions about hormone replacement therapy in postmenopausal women

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks